Literature DB >> 11404118

Depressed myocardial fatty acid metabolism in patients with muscular dystrophy.

M Momose1, N Iguchi, K Imamura, H Usui, T Ueda, K Miyamoto, S Inaba.   

Abstract

Myocardial involvement is frequently associated with various types of muscular dystrophy and Thallium-201 scintigraphy can show regional myocardial perfusion abnormalities in patients with muscular dystrophy. Myocardial fatty acid metabolism can now be imaged using a radioiodinated branched fatty acid (123I-BMIPP). The present study evaluates myocardial fatty acid metabolism in muscular dystrophy. Twenty-eight patients underwent 123I-BMIPP(BMIPP) and Thallium dual single photon emission tomography. Regional uptake of both tracers was visually analyzed. We also assessed electrocardiography and echocardiography. The results showed that the BMIPP uptake compared to Thallium was smaller in 57% of all patients. BMIPP SPECT images revealed abnormalities in four of eight patients with a normal electrocardiogram. Abnormal BMIPP uptake with normal regional wall motion was evident in nine patients. The size of the region with defective BMIPP uptake was larger than that of asynergic areas detected by echocardiography in 11 patients. In conclusion, muscular dystrophy involves depressed myocardial fatty acid metabolism in larger extent of region than that in perfusion or mechanical abnormality.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11404118     DOI: 10.1016/s0960-8966(01)00191-2

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  7 in total

Review 1.  Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: Thematic Review Series: Genetics of Human Lipid Diseases.

Authors:  Harjot K Saini-Chohan; Ryan W Mitchell; Frédéric M Vaz; Teresa Zelinski; Grant M Hatch
Journal:  J Lipid Res       Date:  2011-11-07       Impact factor: 5.922

Review 2.  Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart.

Authors:  Yan Burelle; Maya Khairallah; Alexis Ascah; Bruce G Allen; Christian F Deschepper; Basil J Petrof; Christine Des Rosiers
Journal:  J Mol Cell Cardiol       Date:  2009-09-18       Impact factor: 5.000

3.  RhoA mediates defective stem cell function and heterotopic ossification in dystrophic muscle of mice.

Authors:  Xiaodong Mu; Arvydas Usas; Ying Tang; Aiping Lu; Bing Wang; Kurt Weiss; Johnny Huard
Journal:  FASEB J       Date:  2013-05-23       Impact factor: 5.191

Review 4.  Cardiac involvement in Becker muscular dystrophy.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Can J Cardiol       Date:  2008-10       Impact factor: 5.223

5.  Glucose Metabolism as a Pre-clinical Biomarker for the Golden Retriever Model of Duchenne Muscular Dystrophy.

Authors:  Sarah Morar Schneider; Vidya Sridhar; Amanda K Bettis; Heather Heath-Barnett; Cynthia J Balog-Alvarez; Lee-Jae Guo; Rachel Johnson; Scott Jaques; Stanislav Vitha; Alan C Glowcwski; Joe N Kornegay; Peter P Nghiem
Journal:  Mol Imaging Biol       Date:  2018-10       Impact factor: 3.488

6.  Applications of metabolomics and proteomics to the mdx mouse model of Duchenne muscular dystrophy: lessons from downstream of the transcriptome.

Authors:  Julian L Griffin; Christine Des Rosiers
Journal:  Genome Med       Date:  2009-03-25       Impact factor: 11.117

7.  Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment.

Authors:  Corinne A Betts; Graham McClorey; Richard Healicon; Suzan M Hammond; Raquel Manzano; Sofia Muses; Vicky Ball; Caroline Godfrey; Thomas M Merritt; Tirsa van Westering; Liz O'Donovan; Kim E Wells; Michael J Gait; Dominic J Wells; Damian Tyler; Matthew J Wood
Journal:  Hum Mol Genet       Date:  2019-02-01       Impact factor: 6.150

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.